Right here’s a fast take a look at shares prone to be in focus in right this moment’s commerce.
Tata Consultancy Providers
IT main Tata Consultancy Providers (TCS) notified the exchanges that it’ll launch its July–September quarter outcomes on October 9.
KEC Worldwide
The RPG Group firm has secured new transmission and distribution (T&D) contracts value ₹3,243 crore, which embrace its biggest-ever EPC order for 400 kV transmission strains within the UAE, together with tower, {hardware}, and pole provide initiatives within the Americas.
Hyundai Motor India
In accordance with experiences, Hyundai Motor India registered 11,000 supplier billings on the opening day of the nine-day Navaratri competition, marking its strongest single-day gross sales efficiency within the final 5 years.
Vedanta
In a blow to mining tycoon Anil Agarwal’s conglomerate, the federal government has turned down Vedanta group firm’s request to increase its contract for a vital oil and gasoline block within the Cambay basin.
Rail Vikas Nigam
RVNL has secured the place of the bottom bidder for a ₹145.35 crore Southern Railway venture involving the design, provide, and commissioning of traction substations on the Jolarpettai–Salem route.
IndusInd Financial institution
IndusInd Financial institution has named Viral Damania as its Chief Monetary Officer (CFO) and Key Managerial Personnel, efficient September 22.
Brigade Enterprises
The corporate has entered right into a joint growth deal for a ₹1,200 crore residential venture in Banashankari, South Bengaluru, masking 7.5 acres.
Coforge
The Board of Administrators has cleared the reappointment of D Ok Singh as an Impartial Director for a second five-year time period beginning February 12, 2026, and has additionally permitted the appointment of John Speight as Govt Director for a tenure of as much as 5 years starting October 10, 2025.
Birla Company
The corporate’s fully-owned subsidiary, RCCPL, has been chosen as the popular bidder for the Guda-Rampur limestone and manganese block in Telangana.
Alkem Laboratories
The corporate has launched Pertuza injection 420mg/14mL, a biosimilar of pertuzumab, in India for the therapy of HER2-positive breast most cancers.
Disclaimer: This story is for academic functions solely. The views and proposals above are these of particular person analysts or broking firms, not Mint. We advise traders to verify with licensed consultants earlier than making any funding selections.
